can i switch to semaglutide from tirzepatide Switching Tirzepatide: Is It Safe? Switching from Semaglutide to Tirzepatide

Wegovy (higher-dose semaglutide) targets obesity, Trulicity offers simplified weekly dosing, and Ozempic, a derivative of semaglutide, remains a reliable option for efficient blood sugar control

Eli Lilly and Company, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), has announced positive topline results from a phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes

But some health experts are sounding alarms about the risks associated with the alternative medications

Some individuals report feeling more alert or energised, though this is based on patient experience rather than established clinical evidence

Rai et al